Oxycodone/Naloxone prolonged-release: a review of its use in the management of chronic pain while counteracting opioid-induced constipation.
about
Opioid-induced constipation: advances and clinical guidanceEvolving paradigms in the treatment of opioid-induced bowel dysfunctionConsensus Recommendations on Initiating Prescription Therapies for Opioid-Induced ConstipationClinical potential of naloxegol in the management of opioid-induced bowel dysfunctionChronic opioid induced constipation in patients with nonmalignant pain: challenges and opportunitiesChronic Pain: How Challenging Are DDIs in the Analgesic Treatment of Inpatients with Multiple Chronic Conditions?Luminally Acting Agents for Constipation Treatment: A Review Based on Literatures and Patents.Pain management of the cancer patient.Opioid-Induced Constipation.Is oxycodone/naloxone effective and safe in managing chronic pain of a fragile elderly patient with multiple skin ulcers of the lower limbs? A case report.Efficacy and tolerability of oral oxycodone and oxycodone/naloxone combination in opioid-naïve cancer patients: a propensity analysis.Long-term efficacy and safety of oxycodone-naloxone prolonged release in geriatric patients with moderate-to-severe chronic noncancer pain: a 52-week open-label extension phase study.Naloxegol for the treatment of opioid-induced constipation.Naloxegol , a new drug for the treatment of opioid-induced constipation.Oxycodone/Naloxone PR: A Review in Severe Refractory Restless Legs Syndrome.Opioids in Gastroenterology: Treating Adverse Effects and Creating Therapeutic Benefits.Abuse-deterrent formulations of prescription opioid analgesics in the management of chronic noncancer pain.Pharmacokinetic and pharmacodynamic evaluation of oxycodone and naltrexone for the treatment of chronic lower back pain.Management of Patients on Abuse-Deterrent Opioids in the Ambulatory Surgery Setting.The Risk of Ischemic Cardio- and Cerebrovascular Events Associated with Oxycodone-Naloxone and Other Extended-Release High-Potency Opioids: A Nested Case-Control Study.Efficacy and safety of controlled-release oxycodone/naloxone versus controlled-release oxycodone in Korean patients with cancer-related pain: a randomized controlled trialA comparison between the administration of oral prolonged-release oxycodone-naloxone and transdermal fentanyl in patients with moderate-to-severe cancer pain: a propensity score analysisCould Perioperative Opioid Use Increase the Risk of Cancer Progression and Metastases?Oxycodone/naloxone as a therapeutic option in a patient with chronic pain and opioid-induced bowel dysfunction.Enhanced recovery after surgery: Pain management.Oxycodone/Naloxone Prolonged Release: A Review in Severe Chronic Pain.Prolonged-Release Oxycodone/Naloxone Improves Anal Sphincter Relaxation Compared to Oxycodone Plus Macrogol 3350.Efficacy and safety of oxycodone/naloxone as add-on therapy to gabapentin or pregabalin for the management of chemotherapy-induced peripheral neuropathy in Korea.Can oliceridine (TRV130), an ideal novel µ receptor G protein pathway selective (µ-GPS) modulator, provide analgesia without opioid-related adverse reactions?Is there a role for opioids in the treatment of fibromyalgia?Analgesic Efficacy and Safety of Prolonged-Release Oxycodone/Naloxone in Korean Patients with Chronic Pain from Spinal Disorders.New developments in the treatment of opioid-induced gastrointestinal symptoms
P2860
Q26765571-763B8FF6-67DE-4A03-92A1-71321B8F1000Q26777692-CCF7C64D-AC0A-4AB8-88A7-A175072B3966Q26830397-8F17FDF1-2BC1-410C-8BD9-EA46AD18E022Q26995944-EEAB1650-9F3A-4CA2-B219-7A7D3F03A3CDQ28083547-FA0E00E4-D9B8-4DD9-9F2F-6FCEAB64F50FQ28468436-FC2463E4-203A-46AD-BFBE-86FA91C0BA60Q33854983-450DE285-A556-427C-BE4B-D1BC5D5AE44AQ34452255-18E46670-2033-4026-B2A1-F41B82520511Q34497803-1CCB3404-DE3B-427D-B43D-B50603ACDE8CQ35954344-8C1E19E5-78BB-4A07-BB89-E1723868D546Q36257042-9CF6E573-0941-425C-ADD2-46FAD6F50B8DQ36833660-9FF9A677-717D-48EE-8BB2-D6F2838B09FDQ38249098-2E436160-B689-4F18-B99F-D8D0147D02B0Q38286331-C82D356A-3F12-4188-9D1E-326C063AFD1CQ38541988-953DC5E0-302A-49AF-A466-06D25EAFBDBAQ38772298-69B55867-1C52-48DB-9307-F4A697283A4BQ38799636-C8221C1A-1B14-40F8-AAD7-21E949AAF136Q38851461-33F91EF5-1EDC-45C1-B0D5-AD7CCD65F947Q39157561-E8AA1A2F-97EA-44DB-B7BD-D27024CDF032Q40337254-4A73EEB5-7D16-4CA4-A11A-F0141080111FQ41283815-A95F8F92-355B-4EE3-A1CA-F6CCACEA408CQ41499833-E776A8FC-1A7F-4C18-A326-424CE77FCDC9Q41644051-F17BFD23-0DEB-4139-9355-FA1A9F1BF203Q41956411-2E6FB227-68BC-43E0-A919-BAD866D4CCD2Q43061500-D0758E49-1B8C-4AEE-B0B4-810F0F8ECBCAQ43075620-EC88B1FB-D147-4698-8AED-07DC7B6A40ECQ43365484-A4644076-DFC4-4C28-B53D-D404F69C19FAQ48344983-E9D91176-501C-417A-883E-F6BE4F4E82D2Q52568263-19D3D620-2DAF-4EE6-9AB5-2C53F9A8397CQ53053272-6B3768F4-BB5E-4892-8802-1E354101CF10Q53077848-239649EB-424D-405C-8377-F60AF0131A16Q57063309-57BCFE70-D1BC-4A09-A771-0D89168C4E5E
P2860
Oxycodone/Naloxone prolonged-release: a review of its use in the management of chronic pain while counteracting opioid-induced constipation.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Oxycodone/Naloxone prolonged-r ...... g opioid-induced constipation.
@en
type
label
Oxycodone/Naloxone prolonged-r ...... g opioid-induced constipation.
@en
prefLabel
Oxycodone/Naloxone prolonged-r ...... g opioid-induced constipation.
@en
P2860
P921
P1433
P1476
Oxycodone/Naloxone prolonged-r ...... g opioid-induced constipation.
@en
P2093
Celeste B Burness
P2860
P2888
P304
P356
10.1007/S40265-014-0177-9
P577
2014-03-01T00:00:00Z
P5875
P6179
1035582834